<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19179" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cerebral Cavernous Malformations</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Caton</surname>
            <given-names>Michael T.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shenoy</surname>
            <given-names>Varadaraya Satyanarayan</given-names>
          </name>
          <aff>University of Washington, Seattle</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Caton declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Varadaraya Satyanarayan Shenoy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19179.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A cerebral cavernous malformation (CCM) is an abnormally large collection of "low flow" vascular channels without brain parenchyma intervening between the sinusoidal vessels. Clinically, cerebral cavernous malformations have highly variable presentations. Adding to the confusion, they are also referred to as cavernomas, cavernous angiomas, and cavernous hemangiomas, though CCM is the preferred nomenclature. CCMs range in diameter from under a millimeter to several centimeters and may occur anywhere in the central nervous system with up to 20 percent located in the brainstem. CCM may be diagnosed in both young children and adults and may develop de novo or even regress spontaneously during a patient&#x02019;s lifetime. Thorough knowledge of the natural history of this entity is of paramount importance to avoid unnecessary and potentially morbid interventions. Given the heterogeneity of this condition, the ontogenesis, diagnosis, management strategies for CCM are subjects of ongoing debate and treatment paradigms continue to evolve. This activity reviews the pathogenesis, diagnosis, evaluation, and treatment of cerebral cavernous malformations and emphasizes the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the most common signs and symptoms in patients with cerebral cavernous malformations.</p></list-item><list-item><p>Summarize the diagnostic studies for cerebral cavernous malformations.</p></list-item><list-item><p>Review how to thoroughly evaluate a patient with a new diagnosis of cerebral cavernous malformation.</p></list-item><list-item><p>Explain the role of interprofessional, patient-centered care in the management of patients with cerebral cavernous malformations.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19179&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19179">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19179.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cerebral cavernous malformations (CCMs)&#x000a0;are&#x000a0;abnormally large collections of "low flow" vascular channels without brain parenchyma intervening between the sinusoidal vessels.<xref ref-type="bibr" rid="article-19179.r1">[1]</xref><xref ref-type="bibr" rid="article-19179.r2">[2]</xref>&#x000a0;McCormick (1966) recognized CCMs as one of the four classes of cerebral vascular malformations which include arteriovenous malformations (AVM), developmental venous anomalies (DVA), and capillary telangiectasia. Clinically, CCMs are highly variable in both symptomatic presentation and natural history. Adding to the confusion, CCM has assumed a variety of names in the medical literature including cavernomas, cavernous angiomas, and cavernous hemangiomas, though CCM is the preferred nomenclature.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref>&#x000a0;CCMs range in size from punctate to several centimeters in diameter and may occur anywhere in the central nervous system with up to 20% located in the brainstem.<xref ref-type="bibr" rid="article-19179.r3">[3]</xref>&#x000a0;</p>
        <p>CCM may&#x000a0;be diagnosed in both young children and adults and may develop de novo or even regress spontaneously during a patient&#x02019;s lifetime. A thorough understanding of the natural history of this entity is of paramount importance to avoid unnecessary and potentially morbid interventions. Given the heterogeneity of this condition, the ontogenesis, diagnosis, management&#x000a0;strategies for CCMs are subjects of ongoing debate among neuroscientists and treatment paradigms continue to evolve.</p>
      </sec>
      <sec id="article-19179.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Experts do not fully understand the pathogenesis of CCMs, but the genetic underpinnings have been clarified in recent years. The majority of CCMs are sporadic, but up to 20% follow a familial, autosomal dominant inheritance pattern characterized by the presence of multiple CCMs in a single patient.<xref ref-type="bibr" rid="article-19179.r4">[4]</xref><xref ref-type="bibr" rid="article-19179.r5">[5]</xref>&#x000a0;This has led to the identification of three homologically distinct genes responsible for CCM development: <italic toggle="yes">CCM1</italic>, <italic toggle="yes">CCM2</italic>, and CC<italic toggle="yes">M</italic>3.<xref ref-type="bibr" rid="article-19179.r6">[6]</xref>&#x000a0;Mutations in any one of these genes can result in multifocal CCM and all three show relatively high genetic penetrance<bold>.</bold>&#x000a0;Many authors have proposed&#x000a0;a "two-hit" hypothesis of familial CCM wherein epigenetic or environmental exposure (the second hit) results in CCM gene loss-of-function and may account for the proclivity of these lesions to accumulate over time and with exposure to radiation.<xref ref-type="bibr" rid="article-19179.r7">[7]</xref>&#x000a0;Studies of sporadic CCM support a common pathway involving de novo mutations of CCM genes.<xref ref-type="bibr" rid="article-19179.r6">[6]</xref></p>
        <p>CCM protein products interact with each other and other cellular machinery responsible for a range of functions including cell-cell communication and angiogenesis. The most critical dysfunction found in CCM mutants is endothelial junction permeability, an effect mediated by Notch1 and Rho kinase activity.<xref ref-type="bibr" rid="article-19179.r8">[8]</xref>&#x000a0;This correlates with the characteristic histopathological appearance of CCM which lacks mature vessel wall architecture and mature blood-brain-barrier.<xref ref-type="bibr" rid="article-19179.r9">[9]</xref>&#x000a0;CCMs are distinguished from other cerebral vascular malformations by the absence of direct arteriovenous communication and lack of intervening brain parenchyma.</p>
      </sec>
      <sec id="article-19179.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>CCMs&#x000a0;are the second&#x000a0;most common incidental vascular finding &#x02013; after aneurysms &#x02013; on brain magnetic resonance imaging (MRI), with a prevalence of 1 in 625 neurologically asymptomatic people.<xref ref-type="bibr" rid="article-19179.r10">[10]</xref><xref ref-type="bibr" rid="article-19179.r11">[11]</xref><xref ref-type="bibr" rid="article-19179.r12">[12]</xref><xref ref-type="bibr" rid="article-19179.r13">[13]</xref>&#x000a0;Clinical presentation is bimodal with a significant number of cases detected in both adolescents and middle-aged adults. There is no discernible sex difference in prevalence; however, there is conflicting research as to whether prognosis is different among men and women.<xref ref-type="bibr" rid="article-19179.r14">[14]</xref>&#x000a0;Familial CCM is notably prevalent among persons of northern Mexican ancestry, an effect that has been traced to a common founder mutation.<xref ref-type="bibr" rid="article-19179.r1">[1]</xref>&#x000a0;The incidence of incidentally detected CCM has increased substantially due to the widespread use of magnetic resonance imaging (MRI).<xref ref-type="bibr" rid="article-19179.r15">[15]</xref>&#x000a0;The majority (approximately 75%) of CCMs are found in the supratentorial compartment in predictable proportion to the volume of neural tissue present.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref></p>
      </sec>
      <sec id="article-19179.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The propensity for intra-lesional and extra-lesional hemorrhage is the chief mechanism&#x000a0;underlying the clinical manifestations of CCM. Sluggish blood flow through dysplastic channels results in recurrent thrombosis, calcification, and deposition of hemosiderin along the margins of the lesion.&#x000a0;Hemorrhage into adjacent brain parenchyma can produce focal neurologic deficits (FND), seizure, or a headache prompting the patient to present for evaluation.&#x000a0;Clinical and lifestyle risk factors for a first symptomatic episode of CCM hemorrhage are unknown, but risk factors for re-hemorrhage are well-studied.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref>&#x000a0;The pathogenesis of CCM-related epilepsy has been attributed to peri-lesional&#x000a0;reactive gliosis due to clinically silent micro-hemorrhages<bold>&#x000a0;</bold>which alters conduction adjacent white matter pathways. The observation that seizure-free outcomes are improved when the entire lesion, including the surrounding hemosiderin rim, is resected, supports this.<xref ref-type="bibr" rid="article-19179.r17">[17]</xref></p>
      </sec>
      <sec id="article-19179.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathologically, CCMs are well-circumscribed, multilobate vascular lesions consisting of sinusoidal channels lined by a single layer of epithelium, devoid of smooth muscle and&#x000a0;lacking intervening brain parenchyma. On gross inspection, cavernous malformations appear "mulberry-like."<xref ref-type="bibr" rid="article-19179.r16">[16]</xref></p>
      </sec>
      <sec id="article-19179.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>While the clinical presentation of symptomatic cavernous malformations varies by location,&#x000a0;the most common clinical manifestations are seizures&#x000a0;(50%), intracranial hemorrhage (25%), and focal neurological deficits&#x000a0;(FND) without radiographic evidence of recent hemorrhage&#x000a0;(25%).<xref ref-type="bibr" rid="article-19179.r2">[2]</xref><xref ref-type="bibr" rid="article-19179.r18">[18]</xref>&#x000a0;Supratentorial lesions most commonly present with seizures whereas FND or ataxia is the most common presentation in patients with infratentorial lesions.<xref ref-type="bibr" rid="article-19179.r19">[19]</xref> Up to 20% to 50% of patients are asymptomatic and diagnosed incidentally on brain MRI.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref><xref ref-type="bibr" rid="article-19179.r11">[11]</xref><xref ref-type="bibr" rid="article-19179.r15">[15]</xref>&#x000a0;When CCM is diagnosed, clinicians should perform a thorough history for evidence of prior symptomatic hemorrhage and a comprehensive neurologic exam to assess for the deficit which may otherwise have been unrecognized. Headaches are common in patients with CCM and determining a causal relationship may be difficult.&#x000a0;Similarly, CCM-related epilepsy (CRE) can present a diagnostic challenge as seizure focus may be challenging to localize. The criteria for CRE have been defined by expert consensus and can be broadly categorized as "definite," "probable," or "unrelated to CCM" based proximity of localized seizure focus to the CCM.<xref ref-type="bibr" rid="article-19179.r20">[20]</xref>&#x000a0;Given the high prevalence of familial CCM, the Angioma Alliance advocates obtaining a detailed, 3 generation family history when MRI diagnoses new CCM. When multiple CCM are present, or family history is positive, genetic screening for <italic toggle="yes">CCM1</italic>, <italic toggle="yes">CCM2</italic>, and <italic toggle="yes">CCM3</italic> should be considered. Given the autosomal dominant nature of CCM inheritance, appropriate counseling regarding familial risk is warranted, and risk-benefit discussion regarding testing asymptomatic relatives should be offered.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref></p>
      </sec>
      <sec id="article-19179.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The American College of Radiology (ACR) Appropriateness Criteria provide expert consensus recommendations for acute neurologic symptoms including a headache, FND, altered consciousness.&#x000a0;<xref ref-type="bibr" rid="article-19179.r21">[21]</xref>&#x000a0;When parenchymal hemorrhage is diagnosed, follow-up imaging with contrast-enhanced MRI is indicated to assess for an underlying vascular lesion. Whether symptomatic or incidentally detected, the majority of CCMs&#x000a0;are diagnosed by MRI which has been shown to have nearly 100% sensitivity.<xref ref-type="bibr" rid="article-19179.r5">[5]</xref><xref ref-type="bibr" rid="article-19179.r15">[15]</xref><xref ref-type="bibr" rid="article-19179.r1">[1]</xref><xref ref-type="bibr" rid="article-19179.r22">[22]</xref>&#x000a0;MRI is particularly valuable in identifying multiple lesions in the case of familial CCM.<xref ref-type="bibr" rid="article-19179.r1">[1]</xref>&#x000a0;T2 weighted MRI typically demonstrates a characteristic mixed signal "popcorn" core with a hypointense rim.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref></p>
        <p>The hemosiderin rim lining the margins of CCMs generates a profound signal void on gradient-echo MRI due to the ferromagnetic dephasing of proton spins. The effect is a striking signal void or "blooming" artifact on gradient echo or susceptibility-weighted sequences (SWI) which is easily detected but can overestimate the actual size of the lesion. MRI has, therefore, become the gold standard tool for the diagnosis and staging of CCM. Guidelines for&#x000a0;imaging follow-up of known CCM are not well-established, but it is generally recommended that new symptoms warrant repeat imaging to assess for acute or subacute hemorrhage.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref><xref ref-type="bibr" rid="article-19179.r5">[5]</xref></p>
        <p>CCMs are characteristically angiographically occult&#x000a0;lesions&#x000a0;due to the slow transit of blood via the dysplastic channels save for the frequently associated developmental venous anomalies (DVA).&#x000a0;CT angiography and digital subtraction angiography are therefore of limited utility in the workup of CCM however they may show indirect evidence of CCM by highlighting adjacent DVAs which typically&#x000a0;enhance and opacify briskly on angiogram.<xref ref-type="bibr" rid="article-19179.r23">[23]</xref></p>
        <p>CCM may present on non-contrast head CT (NCCT) as amorphous calcifications, but further imaging with MRI is warranted to confirm the diagnosis unless contraindicated. The principal role of NCCT is the identification of hemorrhage in symptomatic patients. The Angioma Alliance has defined standard definitions of CCM-related hemorrhage and recommended reporting criteria to improve diagnostic consistency and accuracy among neuroimagers and clinicians.<xref ref-type="bibr" rid="article-19179.r5">[5]</xref>&#x000a0;These guidelines define CCM hemorrhage by the temporal concordance of neurologic symptoms and quantitative imaging biomarkers seeking to avoid misattribution of symptoms to clinically silent CCM.</p>
        <p>Advanced MR imaging is playing an increasingly important role in the management of surgically complex CCM. Diffusion tensor imaging (DTI) has been used to identify critical white matter tracts in preoperative planning for brainstem CCM.<xref ref-type="bibr" rid="article-19179.r24">[24]</xref>&#x000a0;Functional MRI techniques such as blood oxygen level-dependent (BOLD) task-activation mapping of language function are highly accurate and non-invasive tools that have proven useful in the preoperative workup of CCM.<xref ref-type="bibr" rid="article-19179.r25">[25]</xref>&#x000a0;Emerging work using high field strength SWI may provide detailed information on the angioarchitecture of CCM, potentially identifying at-risk lesions.<xref ref-type="bibr" rid="article-19179.r26">[26]</xref></p>
      </sec>
      <sec id="article-19179.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Location is the most important factor that determines the natural history of CCM.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref> Because the clinical course of CCM is highly variable and location-dependent, management and therapeutic decision-making require multidisciplinary discussion and a thorough evaluation of the patient risk tolerance profile. When feasible, surgical resection is the preferred treatment option for symptomatic CCM. In select cases, targeted radiotherapy is used to treat lesions that are surgically inaccessible. There is no role for endovascular therapy in CCM.</p>
        <p>Surgical excision is the only definitive treatment for CCM but the decision to operate remains challenging as postoperative morbidity may approach or exceed the complications of the untreated disease.<xref ref-type="bibr" rid="article-19179.r27">[27]</xref>&#x000a0;Conservative management and observation are therefore favored for all patients with solitary CCM who are asymptomatic.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref>&#x000a0;For supratentorial lesions in non-eloquent regions, surgical excision can be curative with high success rates and relatively low complications.<xref ref-type="bibr" rid="article-19179.r28">[28]</xref>&#x000a0;Surgery should, therefore, be considered in this patient population for patients who present with symptomatic hemorrhage. In cases of medically refractory epilepsy, early surgery is favored for amenable lesions, especially if there is high confidence that a solitary CCM is an epileptogenic source.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref><xref ref-type="bibr" rid="article-19179.r17">[17]</xref><xref ref-type="bibr" rid="article-19179.r20">[20]</xref></p>
        <p>CCMs located in the deep gray nuclei and brainstem pose a much greater challenge.&#x000a0;Studies using diffusion tensor imaging and diffusion tensor tractography have shown that up to 82% of patients with brainstem lesions have involvement of corticospinal tract and other major fiber tracts<xref ref-type="bibr" rid="article-19179.r29">[29]</xref>&#x000a0;highlighting the extreme difficulty neurosurgeons face with patient and approach selection. While good outcomes may be achieved in surgically resected brainstem lesions at high-volume, specialized centers, complication rates are high, and new postoperative neurologic deficits are expected (53% of cases).<xref ref-type="bibr" rid="article-19179.r30">[30]</xref>&#x000a0;Long-term outcomes are better for lesions with a pial presentation which may facilitate resection and minimal collateral injury.<xref ref-type="bibr" rid="article-19179.r31">[31]</xref>&#x000a0;Aggressive intervention in the brainstem is therefore reserved only for patients who have suffered a single disabling bleed, or with long life expectancy which may pose a higher cumulative risk for future hemorrhage.<xref ref-type="bibr" rid="article-19179.r2">[2]</xref><xref ref-type="bibr" rid="article-19179.r30">[30]</xref><xref ref-type="bibr" rid="article-19179.r31">[31]</xref> With the utilization of image guidance, appropriate patient and approach selection, and detailed knowledge of the intrinsic brainstem anatomy, these lesions can be safely resected with good outcomes.<xref ref-type="bibr" rid="article-19179.r32">[32]</xref></p>
        <p>The technical goal of surgery should&#x000a0;be, at a minimum, complete lesionectomy.<xref ref-type="bibr" rid="article-19179.r33">[33]</xref>&#x000a0;Seizure outcomes seem to be better if the surrounding hemosiderin-stained gliotic brain is also resected.<xref ref-type="bibr" rid="article-19179.r17">[17]</xref>&#x000a0;With selective adjuncts such as frameless stereotactic guidance, electrocorticography, and intraoperative MRI, microsurgical resection of CCMs has become much safer and more complete. If the lesion is not adjacent to eloquent areas, resecting the hemosiderin-laden gliotic 'pseudocapsule' surrounding the lesion should be strongly considered esp. if treatment indication is intractable seizures. CCM associated developmental venous anomalies (DVA) should be spared during microsurgical resection as they typically drain the surrounding normal brain.&#x000a0;Each case demands a tailored resection technique. Large lesions can be tackled by piecemeal excision while smaller ones may be amenable for en-bloc resection.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref></p>
        <p>Stereotactic radiosurgery (SRS) has long served as an alternative to surgery in symptomatic patients with anatomically foreboding lesions or unfavorable risk profile. SRS is highly accurate and allows targeted delivery of high-dose radiation (typically 11 to 15 Gy) with sparing of adjacent, healthy brain parenchyma. The mechanism of therapeutic SRS is uncertain; lesion size may decrease, remain stable, or even increase and there is no reliable imaging biomarker for successful CCM obliteration as with metastasis and high-flow vascular lesions.<xref ref-type="bibr" rid="article-19179.r34">[34]</xref>&#x000a0;Several series on SRS for CMs suggest that the greatest risk reduction in hemorrhage usually happens after a 2-year latency period. Hasegawa et al. showed that for patients with high-risk, symptomatic, &#x000a0;diencephalic or brainstem CCM, radiotherapy reduced re-hemorrhage rates from 33% to 12.3% in the 2-year post-treatment period with a further reduction in annualized hemorrhage rate to less than 1% after 2 years.<xref ref-type="bibr" rid="article-19179.r35">[35]</xref>&#x000a0;A recent meta-analysis found a modest reduction in hemorrhage rates with a&#x000a0;substantial incidence of radiation-related complications (11%) including new focal neurologic deficits, hydrocephalus, and painful paresthesia.<xref ref-type="bibr" rid="article-19179.r34">[34]</xref>&#x000a0;SRS is also strongly linked to the development of de novo CCM, although such cases rarely become symptomatic.<xref ref-type="bibr" rid="article-19179.r36">[36]</xref>&#x000a0;Because radiation-induced damage in the brainstem can be devastating, SRS is not recommended as a treatment option for brainstem CMs.<xref ref-type="bibr" rid="article-19179.r32">[32]</xref></p>
        <p>CCM is a surgical disease, and the role of medical management is limited but the subject of much ongoing laboratory research. Preclinical animal model studies have recently shown that both statins and targeted Rho-kinase inhibitors may reduce symptoms and lesion progression.<xref ref-type="bibr" rid="article-19179.r37">[37]</xref>&#x000a0;The medical complications of CCM should be managed following evidence-based guidelines. Intraparenchymal hemorrhage due to CCM should follow standard evidence-based guidelines and protocols which have been well-described by expert consensus.<xref ref-type="bibr" rid="article-19179.r38">[38]</xref>&#x000a0;Recent prospective data found no increase in hemorrhage or other adverse events in patients with CCM who are treated with anticoagulant or antiplatelet medications for other purposes.<xref ref-type="bibr" rid="article-19179.r39">[39]</xref></p>
        <p>The risks of surgical morbidity should be weighed against the natural history of the disease. While microsurgical resection is curative for intractable cases, most patients with supratentorial cavernous malformations are managed conservatively either with radiographic and clinical observation alone or in addition to anti-epileptic drugs, as the current first-line management strategy.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref>&#x000a0;Radiosurgery is still seen with an eye of suspicion as its benefit is not conferred for at least 2 to 3 years after treatment, concurrent with the period of temporal hemorrhage clustering. Early results from the use of MRI-guided laser interstitial thermal therapy (LIIT) for cavernous malformation-related epilepsy are promising.<xref ref-type="bibr" rid="article-19179.r40">[40]</xref>&#x000a0;Further use and expansion of such minimally invasive therapies seem assured.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref></p>
      </sec>
      <sec id="article-19179.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Classic CCM rarely poses a diagnostic dilemma as the radiographic differential diagnosis for isolated T2* artifact, a non-enhancing lesion on MRI is limited. When numerous small CCM are present, as is often the case with familial CCM, the differential diagnosis is broad and includes other etiologies of diffuse cerebral microbleeds including cerebral amyloid angiopathy, chronic hypertension, and hemorrhagic or previously treated metastases, among others. Lesion calcification, which can be detected on routine non-contrast head CT, favors the diagnosis of CCM over other types of microbleed. Finally, the co-existence of a developmental venous anomaly (DVA) strongly supports the diagnosis of CCM.<xref ref-type="bibr" rid="article-19179.r23">[23]</xref></p>
      </sec>
      <sec id="article-19179.s11" sec-type="Staging">
        <title>Staging</title>
        <p>The most widely accepted tool for grading CCM was derived from early observations by Zabramski et al. on the MR manifestations of hemorrhage within the lesion.<xref ref-type="bibr" rid="article-19179.r41">[41]</xref>&#x000a0;This classification schema defines type I lesions by the presence of subacute hemorrhage (high T1 signal, days to weeks from ictus), type II lesions as "popcorn" lesions with central T2* blooming, type III as chronic hemorrhage (low T1 and T2 signal, more than 1-month-old) and lastly, type IV CCM corresponding to multiple punctate microhemorrhages visualized on gradient-echo sequences (T2*-weighted).</p>
      </sec>
      <sec id="article-19179.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The natural history of CCM has been characterized in several large studies.<xref ref-type="bibr" rid="article-19179.r4">[4]</xref><xref ref-type="bibr" rid="article-19179.r14">[14]</xref><xref ref-type="bibr" rid="article-19179.r41">[41]</xref><xref ref-type="bibr" rid="article-19179.r18">[18]</xref>&#x000a0;The overall annualized hemorrhage rate in untreated CCM is estimated at 2.4% with a predicted cumulative 5-year risk of hemorrhage 15.8% from the time of diagnosis.<xref ref-type="bibr" rid="article-19179.r22">[22]</xref><xref ref-type="bibr" rid="article-19179.r13">[13]</xref>&#x000a0;For patients with incidentally detected CCM, the risk of hemorrhage is substantially lower, estimated to be 0.33% per year.<xref ref-type="bibr" rid="article-19179.r4">[4]</xref>&#x000a0;Rates of epilepsy in incidental lesions are similarly low at 1% to 2%.<xref ref-type="bibr" rid="article-19179.r20">[20]</xref>&#x000a0;Conversely, patients who have a documented history of CCM hemorrhage are at significantly greater risk of repeat hemorrhage (23% 5-year rate), a finding which has been replicated in&#x000a0;multiple large case series and meta-analyses to date.<xref ref-type="bibr" rid="article-19179.r4">[4]</xref><xref ref-type="bibr" rid="article-19179.r15">[15]</xref><xref ref-type="bibr" rid="article-19179.r22">[22]</xref><xref ref-type="bibr" rid="article-19179.r42">[42]</xref>&#x000a0;CCMs display a phenomenon termed temporal clustering wherein re-hemorrhage&#x000a0;tends to occur, within the first 2 to 3 years after a prior hemorrhage. After this initial&#x000a0;clustering of hemorrhage events, a relatively quiescent period where no overt hemorrhages&#x000a0;occur may be seen.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref><xref ref-type="bibr" rid="article-19179.r43">[43]</xref>&#x000a0;Prior hemorrhage is a significant risk factor for future hemorrhagic events.<xref ref-type="bibr" rid="article-19179.r16">[16]</xref>&#x000a0;Several factors have been associated with CCM rupture including lesion location, size, multiplicity, and the presence of an associated DVA.<xref ref-type="bibr" rid="article-19179.r44">[44]</xref><xref ref-type="bibr" rid="article-19179.r42">[42]</xref><xref ref-type="bibr" rid="article-19179.r22">[22]</xref>&#x000a0;Studies have shown that supratentorial lobar CCMs have a much more benign prognosis than deep lesions in the thalamus, basal ganglia, or posterior fossa. In one study the event rate for superficial lesions was 0% per year while that for deep lesions was 10.6% per year (p = 0.0001).<xref ref-type="bibr" rid="article-19179.r16">[16]</xref><xref ref-type="bibr" rid="article-19179.r45">[45]</xref>&#x000a0;Brainstem CCMs&#x000a0;are the most dangerous and have a high relative event rate (4- to 7-times more likely to rupture than isolated supratentorial lesions).<xref ref-type="bibr" rid="article-19179.r42">[42]</xref><xref ref-type="bibr" rid="article-19179.r30">[30]</xref> In one meta-analysis, non-brainstem hemorrhage rates were reported to be 0.3% per year vs. 2.8% per year for brainstem lesions.<xref ref-type="bibr" rid="article-19179.r42">[42]</xref>&#x000a0;Also of note, the initial presentation of patients with intracranial hemorrhage&#x000a0;(ICH) or focal neurological deficit and brainstem location was independently associated with a hemorrhage over the 5 years after the initial diagnosis.<xref ref-type="bibr" rid="article-19179.r13">[13]</xref><xref ref-type="bibr" rid="article-19179.r16">[16]</xref> &#x000a0;Female gender as a risk factor for hemorrhage remains a topic of debate.<xref ref-type="bibr" rid="article-19179.r14">[14]</xref><xref ref-type="bibr" rid="article-19179.r13">[13]</xref>&#x000a0;In familial CCM, more aggressive CCM behavior has been observed in <italic toggle="yes">CCM3</italic> mutants in contrast with&#x000a0;a more benign clinical course in <italic toggle="yes">CCM1</italic> deletions.<xref ref-type="bibr" rid="article-19179.r46">[46]</xref><xref ref-type="bibr" rid="article-19179.r6">[6]</xref></p>
      </sec>
      <sec id="article-19179.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The risks and benefits of surgical or radiotherapeutic intervention must be assessed on a case-by-case basis, and the prospective risks of untreated CCM must be balanced with the anticipated morbidity of intervention. The overall mortality associated with CCM hemorrhage is low, estimated at 2.2%, but progressive neurologic deficits can accumulate and reduce a patient's quality of life.<xref ref-type="bibr" rid="article-19179.r42">[42]</xref>&#x000a0;In the hands of experienced surgeons with appropriate patient selection, postoperative morbidity can be quite low with one recent estimate of 1.5%.<xref ref-type="bibr" rid="article-19179.r31">[31]</xref>&#x000a0;Nonetheless, when feasible, conservative management may be favorable as shown in one recent prospective study in which CCM excision worsened short-term disability and&#x000a0;increased risk of neurologic deficit or recurrent hemorrhage.<xref ref-type="bibr" rid="article-19179.r27">[27]</xref></p>
      </sec>
      <sec id="article-19179.s14" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Although there are no guidelines on the role of anti-epileptics following surgical resection of CCM, patients are typically maintained on anti-epileptic monotherapy following surgery.<xref ref-type="bibr" rid="article-19179.r47">[47]</xref> Seizure-free outcomes following surgery are dependent on various factors such as pre-operative seizure frequency, the extent of CCM resection, the extent of perilesional "hemosiderin-ring" resection, and timing of surgery relative to the initial presentation.<xref ref-type="bibr" rid="article-19179.r48">[48]</xref><xref ref-type="bibr" rid="article-19179.r49">[49]</xref>&#x000a0;Anti-epileptic drug withdrawal following surgery should be planned with appropriate dose tapering to reduce the risk of seizure recurrence.<xref ref-type="bibr" rid="article-19179.r50">[50]</xref><xref ref-type="bibr" rid="article-19179.r51">[51]</xref></p>
      </sec>
      <sec id="article-19179.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with CCM are encouraged to explore the official website of the multidisciplinary Angioma Alliance (AA). The Angioma Alliance is dedicated to providing up-to-date patient resources including educational videos.</p>
        <p>Information is provided regarding genetic testing, participation in ongoing clinical research, and tissue banking. The Angioma Alliance also provides social support via online forums and social media sites allowing patients and family members to support one another and share their experiences with CCM.</p>
      </sec>
      <sec id="article-19179.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>RhoA/Rho kinase pathway is seen as a potential target for the pharmacotherapeutic treatment of cavernous malformations. Normally, CCM2 and CCM1 act together to suppress RhoA. CCM1 and CCM2 deficiency lead to constitutively active Rho-kinase (ROCK), which destabilizes endothelial cell junctions and vascular permeability.<xref ref-type="bibr" rid="article-19179.r52">[52]</xref>&#x000a0;ROCK suppressants have been experimentally shown to enable vasculogenesis in CCM1-, CCM2-, and CCM3-deficient cells.<xref ref-type="bibr" rid="article-19179.r53">[53]</xref>&#x000a0;Fasudil, a ROCK inhibitor has been shown to decrease the lesion burden in CCM1-deficient mice.<xref ref-type="bibr" rid="article-19179.r54">[54]</xref></p>
        <p>While CCM1, CCM2 or CCM3 deficiencies have been shown to activate bone morphogenic protein (BMP) and transforming growth factor-beta (TGF-beta) causing an endothelial-to-mesenchymal transition (EndoMT), inhibiting either BMP or TGF-beta was found to decrease the lesion burden in CCM-1 deficient mice representing another avenue of research in CCM therapy.<xref ref-type="bibr" rid="article-19179.r55">[55]</xref>&#x000a0;Similarly, suppressing&#x000a0;Beta-catenin was also found to reduce the number and size of cavernous malformations in a CCM3-deficient mice model.<xref ref-type="bibr" rid="article-19179.r56">[56]</xref> These findings demonstrate the importance of a thorough understanding of the molecular biology underpinning CCM.</p>
      </sec>
      <sec id="article-19179.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Comprehensive care for CCM requires an interprofessional effort involving neurosurgeons, epileptologists, neuroradiologists, mental health professionals, specialty certified nurses, and genetic counselors.</p>
        <p>Given the complexity of this disease and its frequent presentation as an incidental finding, patient counseling and risk profile assessment should be performed at the time of diagnosis.&#x000a0;Familial CCM follows an autosomal dominant inheritance pattern; thus, there is consensus agreement that detailed family history/pedigree and consideration of genetic screening for common mutations should be considered (Class I/Level C).<xref ref-type="bibr" rid="article-19179.r2">[2]</xref>&#x000a0;Ancillary care from social workers and mental health providers can address patient anxiety, and support groups such as the Angioma Alliance provide additional support mechanisms.</p>
        <p>Neuroradiology reports should adhere to established reporting guidelines for CCM which clarify the clinical-radiologic correlation of symptoms and imaging findings.<xref ref-type="bibr" rid="article-19179.r5">[5]</xref>&#x000a0;An accurate radiographic description is critical for determining if patients are candidates for conservative or surgical treatment. Brain MRI with gradient echo and susceptibility-weighted sequences are the preferred tools for both diagnosis and follow-up imaging (Class 1/Level C).<xref ref-type="bibr" rid="article-19179.r2">[2]</xref></p>
        <p>Evidence-based consensus guidelines for management have been described and are described in detail elsewhere (see references&#x000a0;<xref ref-type="bibr" rid="article-19179.r2">[2]</xref><xref ref-type="bibr" rid="article-19179.r20">[20]</xref>).&#x000a0;Conservative observation is favored for asymptomatic CCM, and curative surgical resection for CCM with recurrent hemorrhage or refractory epilepsy is supported by Class II/Level A evidence.&#x000a0;For CCM with solitary hemorrhage, case-by-case consideration is warranted. The role of radiosurgery is the subject of ongoing debate for deep or brainstem CCM or lesions involving the eloquent cortex.</p>
      </sec>
      <sec id="article-19179.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19179&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19179">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/cerebral-cavernous-malformations/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19179">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19179/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19179">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19179.s19">
        <fig id="article-19179.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Cerebral cavernous hemangioma Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cavernous__hemangioma__MRI" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19179.s20">
        <fig id="article-19179.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Pontine cavernoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cavernoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19179.s21">
        <fig id="article-19179.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Pontine cavernoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PONTINE__APPROACH" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19179.s22">
        <fig id="article-19179.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Cortical cavernoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cavernoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19179.s23">
        <fig id="article-19179.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Brainstem cavernoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="brainstem__cavernoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19179.s24">
        <fig id="article-19179.image.f6" position="float" orientation="portrait">
          <caption>
            <p>Third ventricular cavernoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="THIRD__VENTRICLE__CAVERNOMA1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19179.s25">
        <fig id="article-19179.image.f7" position="float" orientation="portrait">
          <caption>
            <p>Third ventricular cavernoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="THIRDVENTRICLECAVERNOMA2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19179.s26">
        <title>References</title>
        <ref id="article-19179.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rigamonti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hadley</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Drayer</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hoenig-Rigamonti</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Cerebral cavernous malformations. Incidence and familial occurrence.</article-title>
            <source>N Engl J Med</source>
            <year>1988</year>
            <month>Aug</month>
            <day>11</day>
            <volume>319</volume>
            <issue>6</issue>
            <fpage>343</fpage>
            <page-range>343-7</page-range>
            <pub-id pub-id-type="pmid">3393196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>A Awad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dahlem</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Flemming</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jusue-Torres</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kondziolka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rigamonti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rebeiz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Waggoner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Whitehead</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel.</article-title>
            <source>Neurosurgery</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>665</fpage>
            <page-range>665-680</page-range>
            <pub-id pub-id-type="pmid">28387823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otten</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pizzolato</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Rilliet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Berney</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies].</article-title>
            <source>Neurochirurgie</source>
            <year>1989</year>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>82</fpage>
            <page-range>82-3, 128-31</page-range>
            <pub-id pub-id-type="pmid">2674753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flemming</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Christianson</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Prospective hemorrhage risk of intracerebral cavernous malformations.</article-title>
            <source>Neurology</source>
            <year>2012</year>
            <month>Feb</month>
            <day>28</day>
            <volume>78</volume>
            <issue>9</issue>
            <fpage>632</fpage>
            <page-range>632-6</page-range>
            <pub-id pub-id-type="pmid">22302553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <collab>Angioma Alliance Scientific Advisory Board</collab>
            </person-group>
            <article-title>Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board.</article-title>
            <source>Stroke</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>12</issue>
            <fpage>3222</fpage>
            <page-range>3222-30</page-range>
            <pub-id pub-id-type="pmid">18974380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Labauge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Denier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bergametti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genetics of cavernous angiomas.</article-title>
            <source>Lancet Neurol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-44</page-range>
            <pub-id pub-id-type="pmid">17303530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Gandhi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gujar</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Muraszko</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Gebarski</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Radiation-induced cavernomas of the brain.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>2005</year>
            <month>May</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>1158</fpage>
            <page-range>1158-62</page-range>
            <pub-id pub-id-type="pmid">15891176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zalvide</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Faurobert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Albiges-Rizo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.</article-title>
            <source>Trends Mol Med</source>
            <year>2013</year>
            <month>May</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>302</fpage>
            <page-range>302-8</page-range>
            <pub-id pub-id-type="pmid">23506982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zawistowski</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Stalheim</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Uhlik</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Abell</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Ancrile</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Marchuk</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.</article-title>
            <source>Hum Mol Genet</source>
            <year>2005</year>
            <month>Sep</month>
            <day>01</day>
            <volume>14</volume>
            <issue>17</issue>
            <fpage>2521</fpage>
            <page-range>2521-31</page-range>
            <pub-id pub-id-type="pmid">16037064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greving</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wermer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Morita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Juvela</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yonekura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ishibashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Torner</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rinkel</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Algra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies.</article-title>
            <source>Lancet Neurol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-66</page-range>
            <pub-id pub-id-type="pmid">24290159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Whiteley</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Longstreth</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Tsushima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Alphs</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ladd</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Warlow</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wardlaw</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.</article-title>
            <source>BMJ</source>
            <year>2009</year>
            <month>Aug</month>
            <day>17</day>
            <volume>339</volume>
            <fpage>b3016</fpage>
            <pub-id pub-id-type="pmid">19687093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vernooij</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Ikram</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tanghe</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hofman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krestin</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Niessen</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Breteler</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>van der Lugt</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Incidental findings on brain MRI in the general population.</article-title>
            <source>N Engl J Med</source>
            <year>2007</year>
            <month>Nov</month>
            <day>01</day>
            <volume>357</volume>
            <issue>18</issue>
            <fpage>1821</fpage>
            <page-range>1821-8</page-range>
            <pub-id pub-id-type="pmid">17978290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horne</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Flemming</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Stapf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maxwell</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Christianson</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Agid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ter Brugge</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Willinsky</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <collab>Cerebral Cavernous Malformations Individual Patient Data Meta-analysis Collaborators</collab>
            </person-group>
            <article-title>Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.</article-title>
            <source>Lancet Neurol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>166</fpage>
            <page-range>166-173</page-range>
            <pub-id pub-id-type="pmid">26654287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Curling</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Elster</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Craven</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>An analysis of the natural history of cavernous angiomas.</article-title>
            <source>J Neurosurg</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>75</volume>
            <issue>5</issue>
            <fpage>702</fpage>
            <page-range>702-8</page-range>
            <pub-id pub-id-type="pmid">1919691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Christianson</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Flemming</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort.</article-title>
            <source>J Neurosurg</source>
            <year>2014</year>
            <month>May</month>
            <volume>120</volume>
            <issue>5</issue>
            <fpage>1188</fpage>
            <page-range>1188-92</page-range>
            <pub-id pub-id-type="pmid">24628608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellis</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Barrow</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Supratentorial cavernous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>143</volume>
            <fpage>283</fpage>
            <page-range>283-289</page-range>
            <pub-id pub-id-type="pmid">28552151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baumann</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Schuknecht</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lo Russo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cossu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Citterio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andermann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed.</article-title>
            <source>Epilepsia</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>563</fpage>
            <page-range>563-6</page-range>
            <pub-id pub-id-type="pmid">16529622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Horne</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Moultrie</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Josephson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Counsell</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Papanastassiou</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Sellar</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Warlow</surname>
                <given-names>CP</given-names>
              </name>
              <collab>Scottish Audit of Intracranial Vascular Malformations (SAIVMs) collaborators</collab>
            </person-group>
            <article-title>Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.</article-title>
            <source>Lancet Neurol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-24</page-range>
            <pub-id pub-id-type="pmid">22297119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Washington</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Zipfel</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation.</article-title>
            <source>Neurosurg Focus</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>E7</fpage>
            <pub-id pub-id-type="pmid">20809765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenow</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alonso-Vanegas</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bl&#x000fc;mcke</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Carre&#x000f1;o</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gizewski</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Hamer</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Knake</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kahane</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>L&#x000fc;ders</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Mathern</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Menzler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Otsuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ozkara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pitk&#x000e4;nen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roper</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Sure</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Steinhoff</surname>
                <given-names>BJ</given-names>
              </name>
              <collab>Surgical Task Force, Commission on Therapeutic Strategies of the ILAE</collab>
            </person-group>
            <article-title>Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies.</article-title>
            <source>Epilepsia</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>54</volume>
            <issue>12</issue>
            <fpage>2025</fpage>
            <page-range>2025-35</page-range>
            <pub-id pub-id-type="pmid">24134485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Neurologic Imaging:</collab>
              <name>
                <surname>Salmela</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mortazavi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jagadeesan</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deshmukh</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Hoang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Khalessi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Perlmutter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Policeni</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Setzen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Whitehead</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Cornelius</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Corey</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria<sup>&#x000ae;</sup> Cerebrovascular&#x000a0;Disease.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2017</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5S</issue>
            <fpage>S34</fpage>
            <page-range>S34-S61</page-range>
            <pub-id pub-id-type="pmid">28473091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gross</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>The natural history of intracranial cavernous malformations.</article-title>
            <source>Neurosurg Focus</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>E24</fpage>
            <pub-id pub-id-type="pmid">21631226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petersen</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Schrader</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>377</fpage>
            <page-range>377-82</page-range>
            <pub-id pub-id-type="pmid">19833796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>FX</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>XZ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Surgical outcome of motor deficits and neurological status in brainstem cavernous malformations based on preoperative diffusion tensor imaging: a prospective randomized clinical trial.</article-title>
            <source>J Neurosurg</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>130</volume>
            <issue>1</issue>
            <fpage>286</fpage>
            <page-range>286-301</page-range>
            <pub-id pub-id-type="pmid">29547081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pouratian</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bookheimer</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Rex</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Toga</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Utility of preoperative functional magnetic resonance imaging for identifying language cortices in patients with vascular malformations.</article-title>
            <source>Neurosurg Focus</source>
            <year>2002</year>
            <month>Oct</month>
            <day>15</day>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>e4</fpage>
            <pub-id pub-id-type="pmid">15771403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dammann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wrede</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsushige</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maderwald</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Umutlu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Quick</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Hehr</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Rath</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ladd</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Felbor</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Sure</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.</article-title>
            <source>J Neurosurg</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>570</fpage>
            <page-range>570-577</page-range>
            <pub-id pub-id-type="pmid">27153162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moultrie</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Horne</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Josephson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Counsell</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Papanastassiou</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sellar</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Warlow</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <collab>Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators</collab>
            </person-group>
            <article-title>Outcome after surgical or conservative management of cerebral cavernous malformations.</article-title>
            <source>Neurology</source>
            <year>2014</year>
            <month>Aug</month>
            <day>12</day>
            <volume>83</volume>
            <issue>7</issue>
            <fpage>582</fpage>
            <page-range>582-9</page-range>
            <pub-id pub-id-type="pmid">24994841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Angelo</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>De Bonis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Amoroso</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D'Agruma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guarnieri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Muscarella</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Zelante</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bisceglia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scarabino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Catapano</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Supratentorial cerebral cavernous malformations: clinical, surgical, and genetic involvement.</article-title>
            <source>Neurosurg Focus</source>
            <year>2006</year>
            <month>Jul</month>
            <day>15</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>e9</fpage>
            <pub-id pub-id-type="pmid">16859262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flores</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Whittemore</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Samson</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Barnett</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>The utility of preoperative diffusion tensor imaging in the surgical management of brainstem cavernous malformations.</article-title>
            <source>J Neurosurg</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>122</volume>
            <issue>3</issue>
            <fpage>653</fpage>
            <page-range>653-62</page-range>
            <pub-id pub-id-type="pmid">25574568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abla</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lekovic</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>de Oliveira</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Advances in the treatment and outcome of brainstem cavernous malformation surgery: a single-center case series of 300 surgically treated patients.</article-title>
            <source>Neurosurgery</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>403</fpage>
            <page-range>403-14; discussion 414-5</page-range>
            <pub-id pub-id-type="pmid">21654575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gross</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Batjer</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Bendok</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Brainstem cavernous malformations: 1390 surgical cases from the literature.</article-title>
            <source>World Neurosurg</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>80</volume>
            <issue>1-2</issue>
            <fpage>89</fpage>
            <page-range>89-93</page-range>
            <pub-id pub-id-type="pmid">22484766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atwal</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Sarris</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Brainstem and cerebellar cavernous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>143</volume>
            <fpage>291</fpage>
            <page-range>291-295</page-range>
            <pub-id pub-id-type="pmid">28552152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeon</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients.</article-title>
            <source>Seizure</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-20</page-range>
            <pub-id pub-id-type="pmid">18656386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>QY</given-names>
              </name>
            </person-group>
            <article-title>Stereotactic radiosurgery of brainstem cavernous malformations: a systematic review and meta-analysis.</article-title>
            <source>J Neurosurg</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>120</volume>
            <issue>4</issue>
            <fpage>982</fpage>
            <page-range>982-7</page-range>
            <pub-id pub-id-type="pmid">24506243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasegawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>McInerney</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kondziolka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Flickinger</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lunsford</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>Long-term results after stereotactic radiosurgery for patients with cavernous malformations.</article-title>
            <source>Neurosurgery</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>1190</fpage>
            <page-range>1190-7; discussion 1197-8</page-range>
            <pub-id pub-id-type="pmid">12015835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nimjee</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Bulsara</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy .</article-title>
            <source>Neurosurg Focus</source>
            <year>2006</year>
            <month>Jul</month>
            <day>15</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>e4</fpage>
            <pub-id pub-id-type="pmid">16859257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shenkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lightle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeineddine</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Girard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Rorrer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gallione</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pytel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Marchuk</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
            </person-group>
            <article-title>RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.</article-title>
            <source>Stroke</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>187</fpage>
            <page-range>187-194</page-range>
            <pub-id pub-id-type="pmid">27879448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hemphill</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bendok</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Selim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>D</given-names>
              </name>
              <collab>American Heart Association Stroke Council</collab>
              <collab>Council on Cardiovascular and Stroke Nursing</collab>
              <collab>Council on Clinical Cardiology</collab>
            </person-group>
            <article-title>Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.</article-title>
            <source>Stroke</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>2032</fpage>
            <page-range>2032-60</page-range>
            <pub-id pub-id-type="pmid">26022637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneble</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Soumare</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Herv&#x000e9;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bresson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guichard</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Riant</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tzourio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chabriat</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stapf</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations.</article-title>
            <source>Stroke</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>3196</fpage>
            <page-range>3196-9</page-range>
            <pub-id pub-id-type="pmid">23150651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCracken</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Willie</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Fernald</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Saindane</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Drane</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Barrow</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Magnetic Resonance Thermometry-Guided Stereotactic Laser Ablation of Cavernous Malformations in Drug-Resistant Epilepsy: Imaging and Clinical Results.</article-title>
            <source>Oper Neurosurg (Hagerstown)</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-48</page-range>
            <pub-id pub-id-type="pmid">27959970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zabramski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wascher</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Golfinos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Drayer</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rigamonti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The natural history of familial cavernous malformations: results of an ongoing study.</article-title>
            <source>J Neurosurg</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>422</fpage>
            <page-range>422-32</page-range>
            <pub-id pub-id-type="pmid">8113854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taslimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Modabbernia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amin-Hanjani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies.</article-title>
            <source>Neurology</source>
            <year>2016</year>
            <month>May</month>
            <day>24</day>
            <volume>86</volume>
            <issue>21</issue>
            <fpage>1984</fpage>
            <page-range>1984-91</page-range>
            <pub-id pub-id-type="pmid">27164680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Amin-Hanjani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ojemann</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Ogilvy</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system.</article-title>
            <source>Neurosurgery</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-24; discussion 24-5</page-range>
            <pub-id pub-id-type="pmid">11440436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kashefiolasl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bruder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brawanski</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Seifert</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tritt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Konczalla</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A benchmark approach to hemorrhage risk management of cavernous malformations.</article-title>
            <source>Neurology</source>
            <year>2018</year>
            <month>Mar</month>
            <day>06</day>
            <volume>90</volume>
            <issue>10</issue>
            <fpage>e856</fpage>
            <page-range>e856-e863</page-range>
            <pub-id pub-id-type="pmid">29429974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porter</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Willinsky</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage.</article-title>
            <source>J Neurosurg</source>
            <year>1997</year>
            <month>Aug</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>190</fpage>
            <page-range>190-7</page-range>
            <pub-id pub-id-type="pmid">9254081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Labauge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bergametti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marchelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Riant</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Arnoult</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maciazek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vicaut</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Brunereau</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genotype-phenotype correlations in cerebral cavernous malformations patients.</article-title>
            <source>Ann Neurol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>550</fpage>
            <page-range>550-556</page-range>
            <pub-id pub-id-type="pmid">17041941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rudy</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pharmacotherapy for cavernous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>143</volume>
            <fpage>309</fpage>
            <page-range>309-316</page-range>
            <pub-id pub-id-type="pmid">28552155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Englot</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lawton</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations.</article-title>
            <source>J Neurosurg</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>115</volume>
            <issue>6</issue>
            <fpage>1169</fpage>
            <page-range>1169-74</page-range>
            <pub-id pub-id-type="pmid">21819194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stavrou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frischer</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Trattnig</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Knosp</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients.</article-title>
            <source>Neurosurgery</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>888</fpage>
            <page-range>888-96; discussion 897</page-range>
            <pub-id pub-id-type="pmid">19005379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rathore</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sarma</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>How safe is it to withdraw antiepileptic drugs following successful surgery for mesial temporal lobe epilepsy?</article-title>
            <source>Epilepsia</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>627</fpage>
            <page-range>627-35</page-range>
            <pub-id pub-id-type="pmid">21219315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>L&#x000f6;scher</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience.</article-title>
            <source>Epilepsia</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-86</page-range>
            <pub-id pub-id-type="pmid">14738426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stockton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Shenkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Ginsberg</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.</article-title>
            <source>J Exp Med</source>
            <year>2010</year>
            <month>Apr</month>
            <day>12</day>
            <volume>207</volume>
            <issue>4</issue>
            <fpage>881</fpage>
            <page-range>881-96</page-range>
            <pub-id pub-id-type="pmid">20308363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borikova</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Dibble</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Sciaky</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Welch</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Abell</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Bencharit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.</article-title>
            <source>J Biol Chem</source>
            <year>2010</year>
            <month>Apr</month>
            <day>16</day>
            <volume>285</volume>
            <issue>16</issue>
            <fpage>11760</fpage>
            <page-range>11760-4</page-range>
            <pub-id pub-id-type="pmid">20181950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shenkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stockton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ginsberg</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Marchuk</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
            </person-group>
            <article-title>Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.</article-title>
            <source>Stroke</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>571</fpage>
            <page-range>571-4</page-range>
            <pub-id pub-id-type="pmid">22034008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maddaluno</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rudini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cuttano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bravi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Giampietro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Corada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferrarini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Orsenigo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Papa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boulday</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chapon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Richichi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Retta</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Lampugnani</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Dejana</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>EndMT contributes to the onset and progression of cerebral cavernous malformations.</article-title>
            <source>Nature</source>
            <year>2013</year>
            <month>Jun</month>
            <day>27</day>
            <volume>498</volume>
            <issue>7455</issue>
            <fpage>492</fpage>
            <page-range>492-6</page-range>
            <pub-id pub-id-type="pmid">23748444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19179.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bravi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rudini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cuttano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Giampietro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maddaluno</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ferrarini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Corada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boulday</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dejana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lampugnani</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2015</year>
            <month>Jul</month>
            <day>07</day>
            <volume>112</volume>
            <issue>27</issue>
            <fpage>8421</fpage>
            <page-range>8421-6</page-range>
            <pub-id pub-id-type="pmid">26109568</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
